{"id":"https://openalex.org/W2065003759","doi":"https://doi.org/10.1089/cap.2008.055","title":"Efficacy and Safety of Fluoxetine in Preschool Children with Obsessive-Compulsive Disorder","display_name":"Efficacy and Safety of Fluoxetine in Preschool Children with Obsessive-Compulsive Disorder","alternate_titles":[],"publication_year":2009,"publication_date":"2009-06-01","ids":{"openalex":"https://openalex.org/W2065003759","doi":"https://doi.org/10.1089/cap.2008.055","mag":"2065003759","pmid":"https://pubmed.ncbi.nlm.nih.gov/19519265"},"language":"en","primary_location":{"id":"doi:10.1089/cap.2008.055","doi":"https://doi.org/10.1089/cap.2008.055","is_oa":false,"landing_page_url":"https://doi.org/10.1089/cap.2008.055","pdf_url":null,"source":{"id":"https://openalex.org/S198272637","display_name":"Journal of Child and Adolescent Psychopharmacology","issn_l":"1044-5463","issn":["1044-5463","1557-8992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Child and Adolescent Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2065003759"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022220494","display_name":"Murat Co\u015fkun","orcid":"https://orcid.org/0000-0002-4808-5870","observed_orcids":["https://orcid.org/0000-0002-4808-5870"]},"institutions":[{"id":"https://openalex.org/I67581229","display_name":"Istanbul University","ror":"https://ror.org/03a5qrr21","country_code":"TR","type":"education","lineage":["https://openalex.org/I67581229"]}],"countries":["TR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Murat Coskun","raw_affiliation_strings":["Istanbul University, Turkey","Istanbul University, Istanbul Medical Faculty, Child and Adolescent Psychiatry Department, Istanbul, Turkey. muratcoskun78@yahoo.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istanbul University, Turkey","institution_ids":["https://openalex.org/I67581229"]},{"raw_affiliation_string":"Istanbul University, Istanbul Medical Faculty, Child and Adolescent Psychiatry Department, Istanbul, Turkey. muratcoskun78@yahoo.com","institution_ids":["https://openalex.org/I67581229"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113839539","display_name":"Salih S. Zoroglu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67581229","display_name":"Istanbul University","ror":"https://ror.org/03a5qrr21","country_code":"TR","type":"education","lineage":["https://openalex.org/I67581229"]}],"countries":["TR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Salih Zoroglu","raw_affiliation_strings":["Istanbul University, Turkey","Istanbul University, \u0130stanbul Medical Faculty, Child and Adolescent Psychiatry Department, Istanbul, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istanbul University, Turkey","institution_ids":["https://openalex.org/I67581229"]},{"raw_affiliation_string":"Istanbul University, \u0130stanbul Medical Faculty, Child and Adolescent Psychiatry Department, Istanbul, Turkey","institution_ids":["https://openalex.org/I67581229"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I67581229"],"apc_list":null,"apc_paid":null,"fwci":2.9188,"has_fulltext":false,"cited_by_count":42,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.89184705,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"19","issue":"3","first_page":"297","last_page":"300"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11123","display_name":"Obsessive-Compulsive Spectrum Disorders","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11123","display_name":"Obsessive-Compulsive Spectrum Disorders","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10182","display_name":"Child and Adolescent Psychosocial and Emotional Development","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11132","display_name":"Psychoanalysis and Psychopathology Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fluoxetine","display_name":"fluoxetine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/obsessive-compulsive-disorder","display_name":"obsessive-compulsive disorder","score":0.9940000176429749},{"id":"https://openalex.org/keywords/preschool-children","display_name":"preschool children","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pediatric-ocd","display_name":"pediatric OCD","score":0.4180000126361847},{"id":"https://openalex.org/keywords/behavioral-disinhibition","display_name":"behavioral disinhibition","score":0.6620000004768372},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.6840000152587891},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":0.8659999966621399},{"id":"https://openalex.org/keywords/symptom-severity","display_name":"symptom severity","score":0.7210000157356262},{"id":"https://openalex.org/keywords/antidepressant-efficacy","display_name":"antidepressant efficacy","score":0.527999997138977},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.6190000176429749}],"concepts":[{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.8784699440002441},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.8507623672485352},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5052605271339417},{"id":"https://openalex.org/C3017582312","wikidata":"https://www.wikidata.org/wiki/Q178190","display_name":"Obsessive compulsive","level":2,"score":0.4922873079776764},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.45814248919487},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.38964882493019104},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3532636761665344},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005473","descriptor_name":"Fluoxetine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005473","descriptor_name":"Fluoxetine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005473","descriptor_name":"Fluoxetine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007266","descriptor_name":"Inhibition, Psychological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009771","descriptor_name":"Obsessive-Compulsive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018709","descriptor_name":"Statistics, Nonparametric","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1089/cap.2008.055","doi":"https://doi.org/10.1089/cap.2008.055","is_oa":false,"landing_page_url":"https://doi.org/10.1089/cap.2008.055","pdf_url":null,"source":{"id":"https://openalex.org/S198272637","display_name":"Journal of Child and Adolescent Psychopharmacology","issn_l":"1044-5463","issn":["1044-5463","1557-8992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Child and Adolescent Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:19519265","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19519265","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of child and adolescent psychopharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":9,"referenced_works":["https://openalex.org/W1963701252","https://openalex.org/W1965990281","https://openalex.org/W2042305653","https://openalex.org/W2045664139","https://openalex.org/W2047842365","https://openalex.org/W2063245737","https://openalex.org/W2106992945","https://openalex.org/W2134870270","https://openalex.org/W2153372746"],"related_works":["https://openalex.org/W2080515251","https://openalex.org/W7170780102","https://openalex.org/W2091074718","https://openalex.org/W2106992945","https://openalex.org/W2074155552","https://openalex.org/W3014445673","https://openalex.org/W2047842365","https://openalex.org/W2026317168","https://openalex.org/W2044361563","https://openalex.org/W1988311059"],"abstract_inverted_index":{"OBJECTIVE:":[0],"The":[1,71,104,125],"aim":[2],"of":[3,13,18,42,53,82,127,186,196,205,280],"this":[4,74,144],"study":[5,75],"was":[6,62,130,138],"to":[7,169,215],"investigate":[8],"the":[9,16,65,83,208,229,242,278],"efficacy":[10],"and":[11,58,95,115,150,194,203,219,252,269],"safety":[12],"fluoxetine":[14,54,128],"in":[15,22,140,143,157,200,207,217,228,277,282],"treatment":[17,279],"obsessive-compulsive":[19],"disorder":[20],"(OCD)":[21],"preschool":[23,27,283],"children.":[24,284],"METHOD:":[25],"Six":[26],"children":[28],"(age":[29],"range":[30,126],"40-61":[31],"months;":[32],"mean":[33],"51.5":[34],"+/-":[35,93,102,135,263],"8.8":[36],"months)":[37],"with":[38,46,177],"severe,":[39],"distressing":[40],"symptoms":[41,185],"OCD":[43,142,158,281],"were":[44,76,89,98,213,248],"treated":[45],"an":[47,291],"initial":[48],"5":[49,178],"mg/day":[50,132,179,198],"oral":[51],"dose":[52,192],"by":[55,78],"mouth.":[56],"Baseline":[57],"end-point":[59,96,116],"symptom":[60],"severity":[61,218],"assessed":[63],"using":[64],"Clinical":[66],"Global":[67],"Impressions-Severity":[68],"(CGI-S)":[69],"scale.":[70],"data":[72],"for":[73],"collected":[77],"reviewing":[79],"medical":[80],"records":[81],"subjects.":[84,232],"RESULTS:":[85],"CGI-S":[86,117],"baseline":[87,114],"scores":[88,97,118],"6-7":[90],"(mean":[91,100,133],"6.66":[92],"0.5)":[94],"3-7":[99],"4":[101,166],"1.54).":[103],"Wilcoxon":[105],"nonparametric":[106],"paired":[107],"t-test":[108],"revealed":[109],"a":[110],"significant":[111,184],"difference":[112],"between":[113],"(Z":[119],"=":[120,123,256],"-2.121;":[121],"p":[122],"0.034).":[124],"dosage":[129,226],"5-15":[131],"10":[134],"3.16).":[136],"Fluoxetine":[137,273],"effective":[139,276],"treating":[141],"sample.":[145],"Four":[146],"subjects":[147,182],"showed":[148,153],"much":[149,155],"1":[151,201],"subject":[152,202,234],"very":[154],"improvement":[156,176],"symptoms.":[159],"One":[160,233],"subject,":[161],"who":[162],"discontinued":[163],"medication":[164,206,223],"after":[165],"weeks":[167],"due":[168],"side":[170,239,246,286],"effects,":[171,287],"did":[172,220,235],"not":[173,221,236],"show":[174],"any":[175,238],"fluoxetine.":[180],"Two":[181],"developed":[183],"behavioral":[187],"disinhibition":[188],"(SBD)":[189],"that":[190],"required":[191],"reduction":[193,227],"addition":[195],"0.25-0.5":[197],"risperidone":[199],"discontinuation":[204,224],"second":[209],"subject.":[210],"Side":[211],"effects":[212,247],"mild":[214],"moderate":[216],"require":[222],"or":[225],"remaining":[230],"three":[231],"report":[237],"effects.":[240],"Overall":[241],"most":[243],"frequently":[244],"reported":[245],"SBD,":[249,289],"decreased":[250],"appetite":[251],"weight":[253],"loss":[254],"(n":[255],"3;":[257],"range:":[258],"0-1200":[259],"grams;":[260],"mean,":[261],"466":[262],"546.5":[264],"grams),":[265],"sleep":[266],"disturbance,":[267],"headache,":[268],"abdominal":[270],"pain.":[271],"CONCLUSIONS:":[272],"may":[274],"be":[275],"However":[285],"particularly":[288],"remain":[290],"important":[292],"concern.":[293]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2065003759","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
